Reduction in IL-33 plasma levels might be involved in T cell dysregulation in chronic lymphocytic leukemia.
Division of Hematology, University of Messina, Messina, Italy.
Caterina
C
Musolino
Alessandro
A
Allegra
Mirella
M
Profita
Andrea
A
Alonci
Salvatore
S
Saitta
Anna
A
Bonanno
Demetrio
D
Gerace
Laura
L
Calabrò
Sebastiano
S
Gangemi
D000368:Aged; D000369:Aged, 80 and over; D018951:Antigens, CD20 / Q000097:blood; D017252:CD3 Complex / Q000097:blood; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007108:Immune Tolerance; D000067596:Interleukin-33; D007378:Interleukins / Q000097:blood*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D013601:T-Lymphocytes / Q000276:immunology*; D018418:Th2 Cells / Q000276:immunology; D059016:Tumor Microenvironment / Q000276:immunology
D018951:Antigens, CD20; D017252:CD3 Complex; C506536:IL33 protein, human; D000067596:Interleukin-33; D007378:Interleukins